Israeli Nobel laureate appointed to Protalix BioTherapeutics’ scientific advisory board
Posted on August 6, 2007 • By Deena Levenstein
Category: Science 1 Comment
Protalix BioTherapeutics has invited Nobel laureate Professor Aaron Ciechanover to join their scientific advisory board.
Protalix is a publicly traded Israeli company (AMEX: PLX) that has developed a proprietary plant cell culture technology and an innovative bioreactor system.
Prof. Ciechanover received the Nobel prize in chemistry along with two other Israelis in 2004 for discovering the ubiquitin-mediated proteolytic system. This has lead to a deeper understanding of how cells control certain biological processes by breaking down specific proteins.
Of his recent appointment, Prof. Ciechanover said, “I am pleased to have the opportunity to join such a highly regarded team of accredited and innovative individuals. The study of protein-based therapeutics is an intriguing field with the potential to provide many benefits to our society, and I look forward to working with Protalix to further explore these possibilities.”
If you liked this post, be sure to subscribe to our RSS feed.
About israelplug
Upcoming Events
You may have missed
Tidbits
Search
Subscribe to israelplug
Categories
Sponsors
Pingback: Israeli Nobel laureate Ciechanover appointed to another advisory board